Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China

Journal of General Virology

Volumn 87, Issue 5, 2006, Pages 1181-1188

  Wu, Yuping ^a   Chen, Yulong ^a   Li, Longyu ^b   Yu, Guifang ^c   He, Ying ^a   Zhang, Yanling ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Department of Oncology   (China)

^c ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE; PRIMER DNA; PROTEIN E6; PROTEIN E7; PROTEIN L1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ADULT; AFRICA; ARTICLE; ASIAN; CANCER INCIDENCE; CANCER PATIENT; CHINA; CONTROLLED STUDY; EUROPE; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLE; SEQUENCE ANALYSIS; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS GENE; VIRUS INFECTION; VIRUS ISOLATION;

CAPSID PROTEINS; CARCINOMA, SQUAMOUS CELL; CHINA; FEMALE; GENES, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; MUTATION; ONCOGENE PROTEINS, VIRAL; PROTEIN-TYROSINE KINASES; REPRESSOR PROTEINS; RISK FACTORS; SPECIES SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33646140349     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81649-0     Document Type: Article

References (38)

1. Andersson, S., Alemi, M., Rylander, E., Strand, A., Larsson, B., Sällström, J. & Wilander, E. (2000). Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer 83, 307-310.
2. Baay, M. F. D., Quint, W. G. V., Koudstaal, J., Hollema, H., Duk, J. M., Burger, M. P. M., Stolz, E. & Herbrink, P. (1996). Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 34, 745-747.
3. Berumen, J., Ordoñez, R. M., Lazcano, E. & 7 other authors (2001). Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93, 1325-1330.
4. Bontkes, H. J., van Duin, M., de Gruijl, T. D. & 11 other authors (1998). HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78, 166-171.
5. Chan, P. K. S., Lam, C. W., Cheung, T. H., Li, W. W. H., Lo, K. W. K., Chan, M. Y. M., Cheung, J. L. K., Xu, L. Y. & Cheng, A. F. (2002). Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 186, 696-700.
6. de Boer, M. A., Peters, L. A. W., Aziz, M. F., Siregar, B., Cornain, S., Vrede, M. A., Jordanova, E. S., Kolkman-Uljee, S. & Fleuren, G. J. (2004). Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 94, 488-494.
7. Ellis, J. R. M., Keating, P. J., Baird, J. & 8 other authors (1995). The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1, 464-470.
8. Eschle, D., Dürst, M., ter Meulen, J., Luande, J., Eberhardt, H. C., Pawlita, M. & Gissmann, L. (1992). Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol 73, 1829-1832.
9. Etherington, I. J., Ellis, J. R., Luesley, D. M., Moffitt, D. D. & Young, L. S. (1999). Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol Oncol 72, 56-59.
10. Fujinaga, Y., Okazawa, K., Nishikawa, A., Yamakawa, Y., Fukushima, M., Kato, I. & Fujinaga, K. (1994). Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes 9, 85-92.
11. Gravitt, P. E., Burk, R. D., Lorincz, A. & 7 other authors (2003). A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 12, 477-484.
12. Hildesheim, A. (1997). Human papillomavirus variants: implications for natural history studies and vaccine development efforts. J Natl Cancer Inst 89, 752-753.
13. Hildesheim, A. & Wang, S. S. (2002). Host and viral genetics and risk of cervical cancer: a review. Virus Res 89, 229-240.
14. Ho, L., Chan, S.-Y., Chow, V., Chong, T., Tay, S.-K., Villa, L. L. & Bernard, H.-U. (1991). Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 29, 1765-1772.
15. Hu, X., Pang, T., Guo, Z., Mazurenko, N., Kisseljov, F., Pontén, J. & Nistér, M. (2001). HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients. Br J Cancer 84, 791-795.
16. Kämmer, C., Tommasino, M., Syrjänen, S., Delius, H., Hebling, U., Warthorst, U., Pfister, H. & Zehbe, I. (2002). Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 86, 269-273.
17. Kang, S., Jeon, Y. T., Kim, J. W., Park, N. H., Song, Y. S., Kang, S. B. & Lee, H. P. (2005). Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women. Int J Gynecol Cancer 15, 107-112.
18. Lefevre, J., Hankins, C., Pourreaux, K., Voyer, H. & Coutlée, F. (2003). Real-time PCR assays using internal controls for quantitation of HPV-16 and β-globin DNA in cervicovaginal lavages. Canadian Women's HIV Study Group. J Virol Methods 114, 135-144.
19. Liu, J., Rose, B., Huang, X., Liao, G., Carter, J., Wu, X. & Thompson, C. (2004). Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions. Gynecol Oncol 94, 803-810.
20. Matsumoto, K., Yasugi, T., Nakagawa, S., Okubo, M., Hirata, R., Maeda, H., Yoshikawa, H. & Taketani, Y. (2003). Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer 106, 919-922.
21. Muñoz, N. (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19, 1-5.
22. Nindl, I., Rindfleisch, K., Lotz, B., Schneider, A. & Dürst, M. (1999). Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 82, 203-207.
23. Parkin, D. M., Pisani, P. & Ferlay, J. (1999). Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80, 827-841.
24. Radhakrishna Pillai, M., Sreevidya, S., Pollock, B. H., Jayaprakash, P. G. & Herman, B. (2002). Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. Gynecol Oncol 87, 268-273.
25. Seedorf, K., Krämmer, G., Dürst, M., Suhai, S. & Röwekamp, W. G. (1985). Human papillomavirus type 16 DNA sequence. Virology 145, 181-185.
26. Song, Y. S., Kee, S. H., Kim, J. W., Park, N. H., Kang, S. B., Chang, W. H. & Lee, H. P. (1997). Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and non-cancerous lesions of Korean women. Gynecol Oncol 66, 275-281.
27. Stephen, A. L., Thompson, C. H., Tattersall, M. H., Cossart, Y. E. & Rose, B. R. (2000). Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer 86, 695-701.
28. Terry, G., Ho, L. & Cuzick, J. (1997). Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type. Int J Cancer 73, 651-655.
29. Villa, L. L., Sichero, L., Rahal, P., Caballero, O., Ferenczy, A., Rohan, T. & Franco, E. L. (2000). Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81, 2959-2968.
30. Wu, Y., Chen, Y., Li, Y., Yu, G., Zhang, Y. & He, Y. (2006a). Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35, 264-269.
31. Wu, Y., Chen, Y., Li, Y. & 8 other authors (2006b). Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women. Int J Cancer (in press). doi:10.1002/ijc.21746
32. Xi, L. F., Demers, G. W., Koutsky, L. A., Kiviat, N. B., Kuypers, J., Watts, D. H., Holmes, K. K. & Galloway, D. A. (1995). Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 172, 747-755.
33. Yamada, T., Wheeler, C. M., Halpern, A. L., Stewart, A.-C. M., Hildesheim, A. & Jenison, S. A. (1995). Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69, 7743-7753.
34. Yamada, T., Manos, M. M., Peto, J., Greer, C. E., Muñoz, N., Bosch, F. X. & Wheeler, C. M. (1997). Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71, 2463-2472.
35. Zehbe, I., Wilander, E., Delius, H. & Tommasino, M. (1998). Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58, 829-833.
36. Zehbe, I., Tachezy, R., Mytilineos, J. & 7 other authors (2001). Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94, 711-716.
37. Zehbe, I., Mytilineos, J., Wikström, I., Henriksen, R., Edler, L. & Tommasino, M. (2003). Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum Immunol 64, 538-542.
38. Zhang, J. M. (1986). The distribution and characteristics of carcinoma of the cervix uteri in Lue Yang county. Zhonghua Liu Xing Bing Xue Za Zhi 7, 343-345 (in Chinese).